Cargando…
Methyl-CpG Binding Protein 2 in Alzheimer Dementia
Despite decades of research on Alzheimer disease, understanding the complexity of the genetic and molecular interactions involved in its pathogenesis remains far from our grasp. Methyl-CpG Binding Protein 2 (MeCP2) is an important epigenetic regulator enriched in the brain, and recent findings have...
Autores principales: | Kim, Baeksun, Choi, Yunjung, Kim, Hye-Sun, Im, Heh-In |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Continence Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905210/ https://www.ncbi.nlm.nih.gov/pubmed/31795606 http://dx.doi.org/10.5213/inj.1938196.098 |
Ejemplares similares
-
Subanesthetic ketamine rapidly alters medial prefrontal miRNAs involved in ubiquitin-mediated proteolysis
por: Choi, Yunjung, et al.
Publicado: (2021) -
5-Halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2)
por: Valinluck, Victoria, et al.
Publicado: (2005) -
Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination
por: Cannistraro, Vincent J., et al.
Publicado: (2010) -
Densely methylated DNA traps Methyl-CpG–binding domain protein 2 but permits free diffusion by Methyl-CpG–binding domain protein 3
por: Leighton, Gage O., et al.
Publicado: (2022) -
Comparative study of methyl-CpG-binding domain proteins
por: Roloff, Tim C, et al.
Publicado: (2003)